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Defects in the erythroid lineage in adult Gas6–/– mice. We next exam-
ined whether erythropoiesis was impaired in adult Gas6–/– mice. 





n = 12; P = NS).







































injection (WT, 19% ± 3%; Gas6–/–, 31% ± 4%; n = 12; P < 0.05). The 
Figure 1
Defects in the erythroid lineage of WT and Gas6–/– mice. 
(A and B) Reduced number of erythroid progenitors in fetal 
liver of Gas6–/– mice, analyzed as the number of BFU-Es 
(A) or CFU-Es (B). n = 6 per group. *P < 0.05. (C and D) 
Reduced percentage of Ter-119+ nucleated cells (erythro-
blasts) in adult BM (C; *P = 0.02) and spleen (D; *P < 0.02) 
in Gas6–/– mice. The erythroblasts were quantified as the 
percent of all nucleated cells by flow cytometry. n = 9 per 
group. (E and F) Reduced number of erythroid progenitors 
in the BM of adult Gas6–/– mice, analyzed as the number 
of BFU-Es (E) or CFU-Es (F). n = 8 per group. *P < 0.05. 
Values are mean ± SEM.
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Senescent rbc engulfment by WT and Gas6–/– macrophages. WT 
and Gas6–/– mouse rbc were treated with PHZ to expose phospha-
tidylserine on their surface and then incubated with primary adherent 
BM-derived macrophages. (A and B) Macrophages in phase-contrast 
illumination are indicated by arrowheads; engulfed rbc are denoted by 
arrows. Phagocytosis was impaired in Gas6–/– mice (B) compared with 
WT mice (A). Scale bars: 20 μm. (C) The number of macrophages with 
3 or more internalized rbc was reduced in Gas6–/– mice compared with 
WT mice (n = 250; mean ± SEM; *P = 0.001). Data were reproduced 
in 100% C57BL/6 background (not shown).
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Erythropoietic response to acute anemia in WT (black lines) and Gas6–/– 
(red lines) mice. P values above the graphs denote overall genotypic 
difference during the entire period of analysis, as analyzed by ANOVA 
for repeated measurement statistics. *P < 0.05, standard t test. (A–D) 
Impaired erythropoiesis in Gas6–/– compared with WT mice in response 
to PHZ-induced hemolytic anemia. (A and B) Hematocrit levels (A) 
and reticulocyte indices (B) after 2 PHZ injections on days 0 and 1 
(n = 8). Data were reproduced in 100% C57BL/6 background (Supple-
mental Figure 1). (C and D) Impaired erythropoiesis in Gas6–/– mice in 
response to autoimmune hemolytic anemia, induced by intraperitoneal 
injection of the 34-3C anti-mouse rbc monoclonal antibody (200 μg 
on day 0). (C) Hematocrit levels. (D) Reticulocyte indices (n = 8). (E) 
Impaired erythropoiesis in Gas6–/– splenectomized mice in response 
to injections of PHZ injections on days 0 and 1 (n = 6). (F) Hematocrit 
levels in Gas6–/– and WT mice after PHZ injections on days 0, 1 and 2 
(n = 6). A hematocrit value of 11% (the lowest detectable hematocrit 
level in preterminal mice) was assigned to the mice that died in the 
course of the experiment. Values are mean ± SEM.
Table 1




Tyro3 49.5 ± 9.5 57.8 ± 7.2
Axl 51.5 ± 14.5 53.3 ± 6.5
Mertk 15.3 ± 1.0 15.3 ± 2.5
Erythroblasts were isolated from spleen under steady-state conditions 
using MACS Ter-119 MicroBeads. Gene expression of Tyro3, Axl, and 
Mertk was quantified by real-time PCR relative to the expression of  
β-actin. Values are mean ± SEM.
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ies/102 copies GAPDH, respectively; n = 3; P > 0.5). However, from 
day 3 to day 6, with the generation of more splenic erythroblasts, 
Gas6 mRNA levels increased significantly to 5.81 ± 3.48 copies/102 














Expression of Gas6 and Gas6Rs in erythroblasts. (A) Western blot 
analysis of Axl and Mertk in spleen erythroblasts isolated from WT, 
Tyro3–/–, Axl–/–, and Mertkkd mice. Equal amounts of protein cell lysates 
were loaded per well. (B) Erythropoiesis of Tyro3–/–, Axl–/– or Mertkkd 
mice in response to PHZ. Overall genotypic differences versus WT 
(after Dunnett’s correction for multiple testing) were as follows: Tyro3–/–, 
P = 0.49 (n = 18); Axl–/–, P = 0.007 (n = 9); Mertkkd, P = 0.97 (n = 5). 
(C) WT and Axl–/– mice were subjected to PHZ-induced hemolytic ane-
mia (injections of a half dose of PHZ on days 0 and 1) and treated 
with saline or rGas6 (2 μg daily intraperitoneally). P < 0.05, Axl–/– and 
Axl–/– plus rGas6 versus WT; P > 0.05, Axl–/– versus Axl–/– plus rGas6.
Figure 5
Release of Gas6 from erythroblasts in response to Epo. Western blot 
analysis showing increased levels of Gas6 in cellular extracts and 
medium conditioned by UT7 human erythroid cells in response to 
4 h stimulation with various concentrations of Epo. Total actin levels 
confirm the equal loading of cell protein extracts in each lane. Lanes 
showing Gas6 in cellular extracts were run on the same gel but were 
noncontiguous, as indicated by black lines.
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WT mice (n = 6; P < 0.05). Overall, these data indicate that Gas6 and 
Epo are coordinately regulated and that erythroblasts themselves 
produce Gas6 and release more Gas6 when stimulated by Epo.






























Impaired Epo survival response of Gas6–/– erythroblasts. (A and B) 
TUNEL staining of spleen 3 days after induction of hemolytic anemia 
by PHZ. Black staining with TUNEL denotes localized apoptotic cells 
in WT (A) and Gas6–/– (B) spleen. F, follicle; RP, red pulp. Scale bars: 
100 μm. (C) TUNEL assay of WT and Gas6–/– erythroblasts isolated 6 
days after PHZ injection. Cells were cultured for 16 h in the presence 
or absence of recombinant human Epo at the indicated concentrations. 
The TUNEL assay was quantified by flow cytometry (n = 4); results are 
expressed as the percentage of apoptotic erythroblasts, cells double-
stained for TUNEL and Ter-119. (D) Dead cell count of splenic eryth-
roblasts (Trypan blue+ cells) collected on day 6 after PHZ injection and 
maintained in culture for 24 h in the presence or absence of Epo (1.5 
IU/ml) or Epo plus human rGas6 (400 ng/ml). n = 8 per group. Values 
are mean ± SEM. *P < 0.05 versus WT.
Figure 7
Gas6 is required for adhesion of erythroblasts. (A) Adher-
ence of WT versus Gas6–/– erythroblasts to fibronectin (n = 6), 
a mechanism essential for proliferation, survival, and 
expansion of these cells. The adhesion defect of Gas6–/– 
erythroblasts was corrected by the addition of rGas6. (B) 
Survival response to Epo of WT and Gas6–/– erythroblasts 
adherent to fibronectin (n = 3). Apoptotic adherent erythro-
blasts stained by DAPI were counted as cells with nuclear 
fragmentation. (C) Expression of VLA4 and Ter-119 in 
WT (n = 9) and Gas6–/– (n = 8) spleen determined by flow 
cytometry. VLA4 expression is proportional to Ter-119 
expression. (D) Adherence of WT versus Gas6–/– erythro-
blasts to fibronectin in the presence of 0.9% NaCl (vehicle), 
LY294002, or anti-VLA4 antibody (2 μg/106 cells) (n = 6). 
Values are mean ± SEM. *P < 0.05. Data were reproduced 
in 100% C57BL/6 background (not shown).
research article
































Epo signaling in WT and Gas6–/– erythroblasts. (A and B) Western blot 
analysis of erythroblasts isolated from spleen 6 days after PHZ treat-
ment from WT and Gas6–/– mice. (A) Total and tyrosine-phosphorylated 
(pTyr) EpoR expression in WT and Gas6–/– erythroblasts. (B) Akt phos-
phorylation in response to Gas6 alone (400 ng/ml), Epo alone (10 IU/
ml), or a combination of both. Densitometric quantification of the amount 
of tyrosine-phosphorylated EpoR and total EpoR revealed a compara-
ble ratio of pTyr-EpoR to EpoR in both genotypes (not shown).
Figure 9
Relative cytokine levels in plasma and BM-derived macrophage 
releasate in WT and Gas6–/– mice. A cytokine antibody array 
was performed in a pool of plasma of 8 mice in steady-state 
condition (A) and a pool of releasate of 8 macrophage culture 
samples (B). Relative cytokine expression is shown in AU. 
Cytokines known to inhibit erythropoiesis are indicated in red. 
1, Axl; 2, B lymphocyte chemoattractant; 3, CD40; 4, CD80L; 
5, CD80T; 6, cytokine responsive gene–2; 7, cutaneous T 
cell–attracting chemokine; 8, CXC–chemokine ligand–16; 9, 
eotaxin; 10, eotaxin-2; 11, FasL; 12, fractalkine; 13, G-CSF; 
14, GM-CSF; 15, IFN-γ; 16, IGF-binding protein 3 (IGFBP-3); 
17, IGFBP-5; 18, IGFBP-6; 19, IL-10; 20, IL-12p40/p70; 21, 
IL-12p70; 22, IL-13; 23, IL-17; 24, IL-1α; 25, IL-1β; 26, IL-2; 
27, IL-3; 28, IL-3Rβ; 29, IL-4; 30, IL-5; 31, IL-6; 32, IL-9; 33, 
mouse IL-8 ortholog (KC or Gro-alpha); 34, leptin; 35, leptin 
receptor; 36, LPS-induced CXC chemokine; 37, L-selectin; 38, 
lymphotactin; 39, monocyte chemotactic protein–1 (MCP1); 40, 
MCP5; 41, M-CSF; 42, monokine induced by IFNγ; 43, macro-
phage inflammatory protein 1α (MIP1α); 44, MIP1γ; 45, MIP2; 
46, MIP3α; 47, MIP3β; 48, platelet factor 4; 49, P-selectin; 50, 
RANTES; 51, SCF; 52, SCF1α; 53, soluble TNF-receptor 1 
(sTNF-R1); 54, sTNF-R2; 55, thymus activation regulated che-
mokine; 56, T cell activation gene 3; 57, thymus expressed che-
mokine; 58, tissue inhibitor of metalloproteinase 1; 59, TNF-α; 
60, thrombopoietin; 61, VCAM-1; 62, VEGF.
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Therapeutic potential of rGas6 in acute and chronic anemia. (A and B) 
WT (A) and Gas6–/– mice (B) were subjected to PHZ induced hemolytic 
anemia (injections on day 0 and 1) and treated with saline (control), 
human rGas6 (2 μg daily intraperitoneally), recombinant human Epo 
(10 IU every second day intraperitoneally), or a combination of rGas6 
and Epo. Overall genotypic differences relative to the control of the 
same genotype (calculated after Bonferroni correction for multiple 
testing) were as follows: rGas6-treated WT, P < 0.001; Epo-treated 
WT, P < 0.001; rGas6-treated Gas6–/–, P = 0.004; Epo-treated Gas6–/–, 
P = 0.008; rGas6- and Epo-treated Gas6–/–, P < 0.001. (C) Hematocrit 
levels in transgenic Epo-TAgH mice, a model of stable chronic anemia, 
treated with rGas6 alone or in combination with Epo at the indicated 
doses (in μg and IU, respectively). Values are mean ± SEM (n = 6). 
*P < 0.05 versus control, standard t test.
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31% ± 4% and 50% ± 4%; n = 6; P < 0.001) as well as by rGas6 

























































Model summarizing the role of the Gas6 pathway in erythropoiesis. (A) Gas6 released by erythroblasts in response to Epo interacts with 
Gas6R on the cell surface, leading to signaling for cell survival and possible cell proliferation, maturation, and differentiation, and enhances 
EpoR signaling by activating PI3K and its effector Akt in these cells (autocrine effect). In addition, Gas6 favors adhesion of erythroblasts to 
fibronectin via VLA4/α4β1 integrin activation. (B) Gas6 acts as a bridging molecule between senescent rbc and Gas6Rs, driving engulfment of 
the bound senescent rbc. (C) Interaction of Gas6 and Gas6Rs downregulates the release of erythroid-inhibitory factors from macrophages in 
the erythroblastic island.
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